138 related articles for article (PubMed ID: 30385112)
1. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms.
Honing J; Kievit W; Bookelaar J; Peters Y; Iyer PG; Siersema PD
Gastrointest Endosc; 2019 Apr; 89(4):712-722.e3. PubMed ID: 30385112
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening a population with chronic gastroesophageal reflux.
Nietert PJ; Silverstein MD; Mokhashi MS; Kim CY; Glenn TF; Marsi VA; Hawes RH; Wallace MB
Gastrointest Endosc; 2003 Mar; 57(3):311-8. PubMed ID: 12612508
[TBL] [Abstract][Full Text] [Related]
3. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
Benaglia T; Sharples LD; Fitzgerald RC; Lyratzopoulos G
Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
[TBL] [Abstract][Full Text] [Related]
4. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Rubenstein JH; Inadomi JM; Brill JV; Eisen GM
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
[TBL] [Abstract][Full Text] [Related]
5. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
Gerson L; Lin OS
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
[TBL] [Abstract][Full Text] [Related]
6. Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening.
Sami SS; Moriarty JP; Rosedahl JK; Borah BJ; Katzka DA; Wang KK; Kisiel JB; Ragunath K; Rubenstein JH; Iyer PG
Am J Gastroenterol; 2021 Aug; 116(8):1620-1631. PubMed ID: 34131096
[TBL] [Abstract][Full Text] [Related]
7. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.
Heberle CR; Omidvari AH; Ali A; Kroep S; Kong CY; Inadomi JM; Rubenstein JH; Tramontano AC; Dowling EC; Hazelton WD; Luebeck EG; Lansdorp-Vogelaar I; Hur C
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1397-1404.e7. PubMed ID: 28238953
[TBL] [Abstract][Full Text] [Related]
9. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
10. Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model.
Furneri G; Klausnitzer R; Haycock L; Ihara Z
PLoS One; 2019; 14(3):e0212916. PubMed ID: 30865673
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
Gerson LB; Groeneveld PW; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
Barbiere JM; Lyratzopoulos G
Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
[TBL] [Abstract][Full Text] [Related]
13. Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy.
Moriarty JP; Shah ND; Rubenstein JH; Blevins CH; Johnson M; Katzka DA; Wang KK; Wongkeesong LM; Ahlquist DA; Iyer PG
Gastrointest Endosc; 2018 Jan; 87(1):88-94.e2. PubMed ID: 28455158
[TBL] [Abstract][Full Text] [Related]
14. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS
Singer ME; Smith MS
Dig Dis Sci; 2021 May; 66(5):1572-1579. PubMed ID: 32578042
[TBL] [Abstract][Full Text] [Related]
15. Unsedated transnasal endoscopy for the detection of Barrett's esophagus: systematic review and meta-analysis.
Huibertse LJ; Peters Y; Westendorp D; Siersema PD
Dis Esophagus; 2023 Jan; 36(2):. PubMed ID: 35830873
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
17. Age- and sex-specific yield of Barrett's esophagus by endoscopy indication.
Rubenstein JH; Mattek N; Eisen G
Gastrointest Endosc; 2010 Jan; 71(1):21-7. PubMed ID: 19748616
[TBL] [Abstract][Full Text] [Related]
18. Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett's esophagus.
Shariff MK; Varghese S; O'Donovan M; Abdullahi Z; Liu X; Fitzgerald RC; di Pietro M
Endoscopy; 2016 Feb; 48(2):110-6. PubMed ID: 26535563
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
20. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
